Enhanced immunization after intranasal coadministration of Escherichia coli heat-labile enterotoxin B subunit and human papillomavirus 16-L1 DNA vaccine

Chinese Medical Journal

Volumn 119, Issue 5, 2006, Pages 408-411

  Wang, Jing ^a   Zhao, Chang An ^a   Wang, Kai ^a   Zheng, Jin ^a   Wang, Yi Li ^a   Si, Lü Sheng ^a  

^a XI'AN JIAOTONG UNIVERSITY   (China)

Author keywords

DNA vaccines; Escherichia coli heat labile enterotoxin B subunit; Human papillomavirus type 16

Indexed keywords

ADJUVANT; DNA VACCINE; ESCHERICHIA COLI ENTEROTOXIN; WART VIRUS VACCINE; BACTERIAL TOXIN; CAPSID PROTEIN; ENTEROTOXIN; ENTEROTOXIN LT; ESCHERICHIA COLI PROTEIN; GAMMA INTERFERON; HPV L1 PROTEIN, HUMAN PAPILLOMAVIRUS; IMMUNOLOGICAL ADJUVANT; ONCOPROTEIN; PAPILLOMA VIRUS VACCINE; VIRUS ANTIBODY; VIRUS VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DRUG DESIGN; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HEMAGGLUTINATION INHIBITION TEST; HUMAN PAPILLOMAVIRUS TYPE 16; IMMUNIZATION; INFECTION PREVENTION; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; SEXUALLY TRANSMITTED DISEASE; SPLEEN CELL; STATISTICAL ANALYSIS; UTERINE CERVICITIS; UTERINE CERVIX CANCER; VACCINATION; VIRUS STRAIN; ANIMAL; BIOSYNTHESIS; BLOOD; C57BL MOUSE; GENETICS; IMMUNOLOGY; INTRANASAL DRUG ADMINISTRATION; LYMPHOCYTE ACTIVATION; VIRION;

ADJUVANTS, IMMUNOLOGIC; ADMINISTRATION, INTRANASAL; ANIMALS; ANTIBODIES, VIRAL; BACTERIAL TOXINS; CAPSID PROTEINS; ENTEROTOXINS; ESCHERICHIA COLI PROTEINS; FEMALE; HEMAGGLUTINATION INHIBITION TESTS; HUMAN PAPILLOMAVIRUS 16; IMMUNIZATION; INTERFERON TYPE II; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C57BL; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRUS VACCINES; VACCINES, DNA; VIRAL VACCINES; VIRION;

EID: 33645509499     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.1097/00029330-200603010-00010     Document Type: Article

References (14)

1. Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999; 189:12-19.
2. Coursaget P, Munoz N. Vaccination against infectious agents associated with human cancer. Cancer Surv 1999; 33: 355-381.
3. Harper DM, Franco EL, Wheeler C, Ferris DG, Jenkins D, Schuind A, et al. Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus typus 16 and 18 in young women: a randomized trail. Obstey Gynecol Surv 2005; 60: 171-173.
4. Hofmann KJ, Cook JC, Joyce JG, Brown DR, Schultz LD, George HA, et al. Sequence determination of human papillomavirus 6a and assembly of virus-like particles in saccharomyces cerevisiae. Virology 1995; 209: 506-518.
5. Martinez X, Brandt C, Saddallah F, Tougne C, Barrios C, Wild F, et al. DNA immunization circumvents deficient induction of T helper type 1 and cytotoxic T lymphocyte responses in neonates and during early life. Proc Natl Acad Sci USA 1997; 94: 8726-8731.
6. Fidel PL, Wolf NA, Kukuruga MA. T lymphocytes in the murine vaginal mucosa are phenotypically distinct from those in the periphery. Infect Immun 1996; 64: 3793-3799.
7. Mithell FA, Bergmeier LA, Doyle C, Brookes R, Hussain LA, Wang Y, et al. Homing of mononuclear cells from iliac lymph nodes to the genital and rectal mucosa in non-human primates. Eur J Immunol 1998; 28: 3066-3072.
8. Kiyono H, Fukuyama S. Nalt- versus Peyer's-patchmediated mucosal immunity. Nat Rev Immunol 2004; 4; 698-710.
9. Millar DG, Hirst TR, Snider DP. Escherichia coli heat-labile enterotoxin B subunit is a more potent mucosal adjuvant than its vlosell related homologue, the B subunit of cholera toxin. Infect Immun 2001; 69: 3476-3482.
10. Sun XL, Si LS, Cao ZS, Wang YL, Liu TJ, Guo JF. The establishment of HPV16-L1 eukaryotic expression system and its immunogenicity study. Chin J Virol (Chin) 1999; 15:270-274.
11. Wang J, Li LL, Zheng J, Yu J, Yang XF, Gang YP, et al. Highly efficient expression, purification of recombinant LTB protein and its activity against mucosal immunoadjuvant by nasal immunization. Chin Med J 2003; 116:1115-1117.
12. Zheng J, Ma J, Yang XF, Liu HL, Cheng HW, Si LS, et al. Highly efficient and economical baculovirus expression system for preparing human papillomavirus type16 virus-like particle. Acta Biochim Biophys Sin 2004; 36: 548-552.
13. Song JM, Sun XL, Wang YL, Guo JF, Liu TJ, Si LS. Humoral immune response and in vitro neutralizing antibody assay on co-delivery of protein HPV16L1 virus-like particle with HPV16L1 gene. Chin J Pathol (Chin) 2005; 34: 421-424.
14. Roden RB, Hubbert NL, Kirnbauer R, Breithurd F, Lowy DR, Schiller JT. Papillomavirus L1 caspids agglutinate mouse erythrocytes through a proteinaceous receptor. J Virol 1995; 69: 5147-5151.